Analytical validation of quantitative SARS-CoV-2 subgenomic and viral load laboratory developed tests conducted on the Panther Fusion® (Hologic) with preliminary application to clinical samples
Open Access
- 29 June 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0287576
Abstract
Objective: Validate the performance characteristics of two analyte specific, laboratory developed tests (LDTs) for the quantification of SARS-CoV-2 subgenomic RNA (sgRNA) and viral load on the Hologic Panther Fusion® using the Open Access functionality. Methods: Custom-designed primers/probe sets targeting the SARS-CoV-2 Envelope gene (E) and subgenomic E were optimized. A 20-day performance validation following laboratory developed test requirements was conducted to assess assay precision, accuracy, analytical sensitivity/specificity, lower limit of detection and reportable range. Results: Quantitative SARS-CoV-2 sgRNA (LDT-Quant sgRNA) assay, which measures intermediates of replication, and viral load (LDT-Quant VLCoV) assay demonstrated acceptable performance. Both assays were linear with an R2 and slope equal to 0.99 and 1.00, respectively. Assay precision was evaluated between 4–6 Log10 with a maximum CV of 2.6% and 2.5% for LDT-Quant sgRNA and LDT-Quant VLCoV respectively. Using negative or positive SARS-CoV-2 human nasopharyngeal swab samples, both assays were accurate (kappa coefficient of 1.00 and 0.92). Common respiratory flora and other viral pathogens were not detected and did not interfere with the detection or quantification by either assay. Based on 95% detection, the assay LLODs were 729 and 1206 Copies/mL for the sgRNA and VL load LDTs, respectively. Conclusion: The LDT-Quant sgRNA and LDT-Quant VLCoV demonstrated good analytical performance. These assays could be further investigated as alternative monitoring assays for viral replication; and thus, medical management in clinical settings which could inform isolation/quarantine requirements.Keywords
Funding Information
- U.S. Army Medical Research Acquisition Activity (. W81-XWH-18-C-0337)
- CHIDA (W81XWH-18-2-0040)
This publication has 31 references indexed in Scilit:
- Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing FacilityNew England Journal of Medicine, 2020
- The Panther Fusion System with Open Access Functionality for Laboratory-Developed Tests for Influenza A Virus SubtypingJournal of Clinical Microbiology, 2020
- Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic SamplesClinical Infectious Diseases, 2020
- The Architecture of SARS-CoV-2 TranscriptomeCell, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther FusionJournal of Clinical Virology, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Performance evaluation of the Panther Fusion® respiratory tract panelJournal of Clinical Virology, 2020
- Evaluation of a laboratory-developed test for simultaneous detection of norovirus and rotavirus by real-time RT-PCR on the Panther Fusion® systemEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Uncoupling RNA virus replication from transcription via the polymerase: functional and evolutionary insightsThe EMBO Journal, 2007